Related Experiment Video

Updated: Feb 13, 2026

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

988

Protease-Activated Receptor-2 Promotes Metastasis: An Emerging Therapeutic Target

Amando A Strong1, Marguerite S Buzza1,2,3,4, Toni M Antalis1,2,3,4

  • 1Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland.

Molecular Cancer Research : MCR
|February 12, 2026
PubMed

Insights

Tumor metastasis, a major cause of cancer death, involves Protease-activated receptor-2 (PAR-2) signaling. Repurposing PAR-2 inhibitors may offer new treatments for advanced cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Tumor metastasis is the primary cause of cancer-related mortality, with limited effective therapeutic interventions.
  • Protease-activated receptor-2 (PAR-2), a G protein-coupled receptor, is activated by proteolytic cleavage.
  • PAR-2 and activating proteases are overexpressed in advanced cancers, suggesting a role in metastasis.

Purpose of the Study:

  • To review the molecular mechanisms by which PAR-2 signaling drives metastatic progression.
  • To explore the therapeutic potential of PAR-2 antagonists in treating advanced malignancies.

Main Methods:

  • Review of existing literature on PAR-2 signaling in cancer metastasis.
  • Analysis of the role of PAR-2 in cellular processes contributing to metastasis.
  • Evaluation of pharmacological inhibitors of PAR-2 for repurposing in cancer therapy.

Main Results:

  • PAR-2 signaling is implicated in multiple cellular processes crucial for metastatic progression.
  • PAR-2 inhibitors, originally developed for pain and inflammation, may target cancer metastatic vulnerabilities.
  • PAR-2 antagonists show potential for use alone or in combination with existing cancer treatments.

Conclusions:

  • PAR-2 signaling is a key driver of tumor metastasis.
  • Targeting PAR-2 with repurposed inhibitors presents a promising strategy to improve outcomes for patients with advanced cancers.
  • Further research into PAR-2 antagonists could lead to novel therapeutic approaches for metastatic disease.

More Related Videos

Use of the Protease Fluorescent Detection Kit to Determine Protease Activity09:00

Use of the Protease Fluorescent Detection Kit to Determine Protease Activity

Published on: August 4, 2009

28.9K
Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.7K

Related Concept Videos

Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Emerging Adulthood01:27

Emerging Adulthood

Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
725
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.6K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
379